Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 1:26 pm Sale | 13G | Oncocyte Corp OCX | PURA VIDA INVESTMENTS LLC | 616,587 4.570% | -91,585 (-12.93%) | View |
| 2024-10-24 12:13 pm Purchase | 13G | Oncocyte Corp OCX | BIO-RAD LABORATORIES INC. BIO | 1,510,944 8.970% | 310,835 (+25.90%) | View |
| 2024-10-09 5:03 pm Purchase | 13G | Oncocyte Corp OCX | SMITH PATRICK W | 1,013,321 6.000% | 1,013,321 (New Position) | View |
| 2024-04-22 1:30 pm Purchase | 13G | Oncocyte Corp OCX | BIO-RAD LABORATORIES INC. BIO | 1,200,109 8.990% | 1,200,109 (New Position) | View |
| 2024-04-15 7:26 pm Purchase | 13D | Oncocyte Corp OCX | BROADWOOD PARTNERS L.P. | 5,079,316 37.600% | 5,079,316 (New Position) | View |
| 2024-02-14 5:03 pm Sale | 13G | Oncocyte Corp OCX | PURA VIDA INVESTMENTS LLC | 708,172 8.450% | -15,933,652 (-95.74%) | View |
| 2024-02-14 3:47 pm Sale | 13G | Oncocyte Corp OCX | AWM Investment Company Inc. | 754,286 9.100% | -6,499,936 (-89.60%) | View |
| 2023-04-14 4:31 pm Sale | 13G | Oncocyte Corp OCX | PURA VIDA INVESTMENTS LLC | 16,641,824 9.990% | -1,414,450 (-7.83%) | View |
| 2023-04-07 10:38 am Purchase | 13D | Oncocyte Corp OCX | BROADWOOD PARTNERS L.P. | 57,131,187 33.300% | 26,918,288 (+89.10%) | View |
| 2023-02-14 1:11 pm Unchanged | 13G | Oncocyte Corp OCX | PURA VIDA INVESTMENTS LLC | 18,056,274 15.220% | 0 (Unchanged) | View |
| 2023-02-14 11:33 am Purchase | 13G | Oncocyte Corp OCX | PURA VIDA INVESTMENTS LLC | 18,056,274 15.220% | 5,832,321 (+47.71%) | View |
| 2023-02-14 11:23 am Purchase | 13G | Oncocyte Corp OCX | AWM Investment Company Inc. | 7,254,222 6.100% | 7,254,222 (New Position) | View |
| 2022-11-23 5:52 pm Purchase | 13G | Oncocyte Corp OCX | Norfield Capital LLC | 6,600,359 5.500% | 6,600,359 (New Position) | View |
| 2022-07-28 5:06 pm Purchase | 13D | Oncocyte Corp OCX | BROADWOOD PARTNERS L.P. | 30,212,899 24.100% | 6,437,935 (+27.08%) | View |
| 2022-05-09 3:23 pm Purchase | 13G | Oncocyte Corp OCX | BlackRock Inc. BLK | 5,005,216 4.200% | 12,070 (+0.24%) | View |
| 2022-04-18 3:56 pm Purchase | 13G | Oncocyte Corp OCX | Halle Special Situations Fund LLC | 7,129,456 6.000% | 7,129,456 (New Position) | View |
| 2022-04-15 5:21 pm Purchase | 13D | Oncocyte Corp OCX | BROADWOOD PARTNERS L.P. | 23,774,964 19.990% | 5,939,374 (+33.30%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Oncocyte Corp OCX | BlackRock Inc. BLK | 4,993,146 5.400% | 1,398,115 (+38.89%) | View |
| 2021-09-24 4:40 pm Unchanged | 13D | Oncocyte Corp OCX | BROADWOOD PARTNERS L.P. | 17,835,590 19.300% | 0 (Unchanged) | View |
| 2021-02-10 3:04 pm Purchase | 13G | Oncocyte Corp OCX | BlackRock Inc. BLK | 3,595,031 4.600% | 93,000 (+2.66%) | View |